Drawing for GLYCOTOPE

USPTO serial 86806180

GLYCOTOPE

Reviewed by CopyMark Law Group

Reg. 5202671Status 704Renewal
Filing date
Status date
Registration date
May 16, 2017
Examiner
GOODSAID, IRA
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with GLYCOTOPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LEIGH ANN LINDQUIST

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in [ industry and ] science; [ photographic chemicals; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilizers; fire extinguishing compositions; tempering preparations; soldering fluxes; fermentation extract; chemicals for fermenting wine; tanning agents for use in the manufacture of leather; adhesives for industrial use; bacterial preparations other than for medical and veterinary use; cells for scientific and research use; biological preparation for use in cell cultures other than for medical or veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; ] chemical preparations for scientific purposes [ ; biochemical and chemical reagents used for non-medical purposes; diagnostic preparations, other than for medical or veterinary purposes; Enzymes for the brewing, detergents and food industries; protein for industrial use; carbohydrates used as an ingredient in the manufacture of nutraceuticals; cultures of microorganisms, other than for medical and veterinary use; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; milk ferments for industrial purposes ]ACTIVE—
005Pharmaceutical preparations [, veterinary preparations, medicines and biological preparations ] for use in prophylaxis or treatment of cancer, [ inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, reproduction medicine and for use in wound healing and formation of blood and tissue; sanitary preparations for medical use; dietetic foods, namely, milk, milk products, milk ferments, whey, kefir, yoghurt, cream and cheese adapted for medical use; food for babies; medical plasters; medical dressings; materials for dental fillings and for making dental impressions; disinfectants; preparations for destroying vermin; fungicides and herbicides; adjuvants for medical purposes; antiallergic medicines; enzyme preparations for medical purposes; protein supplements; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; ] cells for medical or clinical use [ ; cultures of microorganisms for medical or veterinary use; vaccines; nutritional supplements, namely, carbohydrates in powdered form; medicinal drinks; milk ferments for pharmaceutical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables and microorganisms; micro-nutrient preparations for the prevention of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases and gastrointestinal diseases; dietetic sugar for medical use ]ACTIVE—
042[ Scientific and technological services, namely, scientific research, analysis and testing in the fields of chemicals, foods and pharmaceuticals; Industrial research in the fields of chemicals, foods and pharmaceuticals; design and development of computer hardware and software; biological research; chemical laboratories; ] scientific laboratory services specializing in biologics; [ technical surveying; scientific surveying; ] research and development in the fields of [ bacteriology, cellular engineering, cytology, ] antibodies, [ glycomics, chemistry, microorganisms, ] proteins, immunology, biological therapeutics [, nutraceuticals, nutritional supplements and protein and peptide expression systems; quality control for others; research and development of new products for others; technical consulting in the field of pharmaceutical studies; scientific consulting and research services relating to foods and dietary supplements ]ACTIVE—
044[ Medical services; veterinary services; hygienic and beauty care for human beings and animals; agricultural advice; horticultural services; forest habitat restoration; pharmaceutical advice; medical laboratory services; physical examination services; conducting medical examinations for insurance purposes; food nutrition consultation; consulting services in the field of health ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 24, 2024NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 24, 20248.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Jan 24, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 15, 2023ES8RTEAS SECTION 8 RECEIVED—
May 16, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 16, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2017FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jan 20, 2017ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jan 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jan 12, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 12, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 12, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 21, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 21, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 21, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 20, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 20, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 20, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2016DOCKASSIGNED TO EXAMINER—
Nov 6, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 5, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance